¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Bietti crystalline dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® muscular dystrophy ÇÑ±Û ±ÙÀ°ÅðÇàÀ§Ãà
¼³¸í   
  ±Ù¼¶À¯ÀÇ ÆÄ±«·Î ÀÎÇÑ Á¡ÁøÀûÀΠ±ÙÀ§Ãà°ú Çã¾àÀ» Æ¯Â¡À¸·Î Çϴ ÀÏ·ÃÀÇ ¼±ÃµÀûÀΠÁúȯ±ºÀ» ÅëÅо»ÇÑ´Ù. ´ëÇ¥ÀûÀΠ°æ¿ì°¡ µÚ½¨(Duchenne)ÇüÀ¸·Î ¼º¿°»öü ¿­¼ºÀ¯ÀüÀ» Çϸç, ´ë°³ 4 ¼¼À̳»¿¡ ¹ßº´Çؠû³â±â¸¦ ³Ñ±â´Â °æ¿ì°¡ µå¹°´Ù. Æ¯Â¡Àû ¼Ò°ßÀ¸·Î ÀåµýÁö±Ù(gastronemius)ÀÇ °ÅÁþºñ´ë(pseudohypertrophy)(½ÇÁ¦ÀûÀ¸·Î´Â ±ÙÀ§ÃàÀÌ ÀϾÁö¸¸, ±Ù¼¶À¯ ´ë½Å¿¡ Áö¹æ¼¼Æ÷°¡ µé¾îÂ÷ µµ¸®¾î ¸¶Ä¡ ±ÙÀ°ÀÌ Áõ°¡ÇÑ °Íó·³ º¸À̴ Çö»ó) ¼Ò°ßÀ» º¼ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crystalline
    °áÁ¤-
  • crystalline gel
    °áÁ¤°Ö
  • crystalline germ
    °áÁ¤ÇÙ
  • crystalline insulin
    °áÁ¤Àν¶¸°
  • crystalline lens
    ¼öÁ¤Ã¼
  • crystalline substance
    °áÁ¤¹°Áú
  • adiposogenital dystrophy
    Áö¹æÁõ»ý½Ä±âÅðÇàÀ§Ãà
  • Becker muscular dystrophy
    º£Ä¿±Ù(À°)µð½ºÆ®·ÎÇÇ
  • dystrophy
    ÀÌ»óÁõ, µð½ºÆ®·ÎÇÇ, ¿µ¾çÀå¾Ö
  • facioscapulohumeral muscular dystrophy
    ¾ó±¼¾î±úÀ§ÆÈ±ÙÀ°µð½ºÆ®·ÎÇÇ
  • Fuchs endothelial dystrophy
    Ç«½º³»ÇǼ¼Æ÷ÀÌ»óÁõ
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ»óÁõ
  • infantile neuroaxonal dystrophy
    ¿µ¾Æ½Å°æÃà»èµð½ºÆ®·ÎÇÇ
  • lattice corneal dystrophy
    °ÝÀÚ°¢¸·ÀÌ»óÁõ
  • limb-girdle muscular dystrophy
    ÆÈ´Ù¸®ÀÌÀ½±Ù(À°)µð½ºÆ®·ÎÇÇ, Áö´ë±Ùµð½ºÆ®·ÎÇÇ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dystrophy
    ÅðÇàÀ§Ãà, ¿µ¾çÀå¾Ö, ÀÌ»óÁõ, µð½ºÆ®·ÎÇÇ
  • muscular dystrophy
    ±ÙÀ°ÅðÇàÀ§Ãà
  • reflex sympathetic dystrophy
    ¹Ý»ç±³°¨½Å°æÀÌ»óÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crystalline
    °áÁ¤-
  • crystalline gel
    °áÁ¤°Ö
  • crystalline germ
    °áÁ¤ÇÙ
  • crystalline insulin
    °áÁ¤Àν¶¸°
  • crystalline lens
    ¼öÁ¤Ã¼
  • crystalline substance
    °áÁ¤¹°Áú
  • adiposogenital dystrophy
    Áö¹æÁõ¼º±âÅðÇàÀ§Ãà
  • dystrophy
    ÅðÇàÀ§Ãà, ¿µ¾çÀå¾Ö, ÀÌ»óÁõ
  • dermo-chondro-corneal dystrophy
    ÇǺο¬°ñ°¢¸·ÀÌ»óÁõ
  • facioscapulohumeral muscular dystrophy
    ¾ó±¼¾î±úÀ§ÆÈ±ÙÀ°ÅðÇàÀ§Ãà
  • granular corneal dystrophy
    °ú¸³°¢¸·ÀÌ»óÁõ
  • infantile neuroaxonal dystrophy
    ¿µ¾Æ½Å°æÃà»èÅðÇàÀ§Ãà
  • lattice corneal dystrophy
    °ÝÀÚ°¢¸·ÀÌ»óÁõ
  • limb-girdle muscular dystrophy
    »çÁö¿¬°á±ÙÀ°ÅðÇàÀ§Ãà, ÆÈ´Ù¸®ÀÌÀ½±ÙÀ°ÅðÇàÀ§Ãà
  • macular corneal dystrophy
    ¹ÝÁ¡°¢¸·ÀÌ»óÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fuchs dystrophy
    Ç«½ºÀÌ¿µ¾çÁõ
  • Groenouws dystrophy
    ±×·Ú³ëÀÌ¿µ¾ç(Áõ)
  • Meesman dystrophy
    ¹Ì½º¸¸ÀÌ¿µ¾ç(Áõ)
  • Meesmans corneal dystrophy
    ¹Ì½º¸¸°¢¸·ÀÌ¿µ¾ç(Áõ)
  • Salzmanns nodular corneal dystrophy
    ÀßÂ길°áÀý°¢¸·ÀÌ¿µ¾ç(Áõ)
  • albipunctate retinal dystrophy
    ÈòÁ¡¸Á¸·ÀÌ¿µ¾ç(Áõ)
  • hereditary corneal dystrophy
    À¯Àü¼º°¢¸·ÀÌ¿µ¾çÁõ.
  • hereditary corneal dystrophy
    À¯Àü¼º °¢¸·ÀÌ ¿µ¾çÁõ.
  • hereditary macular dystrophy
    À¯Àü¼ºÈ²¹ÝÀÌ¿µ¾ç(Áõ)
  • infantile neuroaxonal dystrophy
    ¿µ¾Æ½Å°æÃà»è¼º ÀÌ¿µ¾çÁõ, »çÀÌÅйö°Å¾¾º´.
  • peroneal muscular dystrophy
    ºñ°ñ±ÙÀ§ÃàÁõ(Þ¡ÍéÐÆê×õêñø)
  • pigmentary retinal dystrophy
    »ö¼Ò¸Á¸·ÀÌ¿µ¾çÁõ, ¸Á¸·»ö¼Òº¯¼º
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõÐÉì¶ç½å×ñø).
  • progressive muscle dystrophy
    ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ(òäú¼àõ ì¶ç½å×ñø)
  • pseudohypertrophy,in muscular dystrophy
    ±ÙÀÌ¿µ¾ç(Áõ)ÀÇ ¡­(ÐÉì¶ç½å×(ñø)¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crystalline corneal dystrophy
    °áÁ¤°¢¸·ÀÌ¿µ¾ç(Áõ)
  • crystalline
    °áÁ¤¼ºÀÇ
  • crystalline gel
    °áÁ¤°Ö.
  • crystalline germ
    °áÁ¤ÇÙ.
  • crystalline granule
    °áÁ¤°ú¸³.
  • crystalline insulin
    °áÁ¤¼º Àν¶¸°.
  • crystalline lens
    ¼öÁ¤Ã¼(â©ïÜô÷).
  • crystalline substance
    °áÁ¤¹°Áú.
  • crystalline zinc insulin
    °áÁ¤¼º ¾Æ¿¬(Ì¿ïÜàõ䬿ç)Àν¶¸°.
  • adrenogenital dystrophy
    ºÎ½Å¼º±â¹ßÀ°ÀÌ»ó(ÜùãìàõÐïÛ¡ëÀì¶ßÈ), ºÎ½Å¼º±âÀÌ¿µ¾çÁõ(¡­ì¶ç½å×ñø).
  • albipunctate retinal dystrophy
    ÈòÁ¡¸Á¸·ÀÌ¿µ¾ç(Áõ)
  • basement membrane dystrophy
    ±âÀú¸·ÀÌ¿µ¾ç(Áõ)
  • beckers muscular dystrophy
    º£Ä¿ ±ÙÀÌ¿µ¾çÁõ(¡­ÐÉì£ç½å×ñø)
  • butterfly corneal dystrophy
    ³ªºñ¸ð¾ç°¢¸·ÀÌ¿µ¾ç(Áõ), Á¢Çü°¢¸·ÀÌ¿µ¾ç(Áõ)
  • butterfly-shaped retinal dystrophy
    ³ªºñ¸ð¾ç¸Á¸·ÀÌ¿µ¾ç(Áõ), Á¢Çü¸Á¸·ÀÌ¿µ¾ç(Áõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adrenogenital dystrophy
    ºÎ½Å¼º±â¹ßÀ°ÀÌ»ó
  • dystrophy
    ÀÌ¿µ¾çÁõ, ¿µ¾ç½ÇÁ¶, ±â´ÉÀå¾Ö, À§ÃàÁõ
  • muscular dystrophy
    ±ÙÀÌ¿µ¾çÁõ
  • progressive muscle dystrophy
    ÁøÇ༺±ÙÀÌ¿µ¾çÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PMD Progressive Muscular Dystrophy; ÁøÇ༺ ±ÙÀÌ¿µ¾çÁõ
  Types of PMD(Progressive Muscular Dystroph...
CMD campomelic dysplasia; camptomelic dwarfism; cartilage matrix deficiency; chief medical director; chi...
LCD coal tar solution [liquor carbonis detergens]; lattice corneal dystrophy; liquid crystal diode; loca...
MD Doctor of Medicine [Lat. Medicinae Doctor]; magnesium deficiency; main duct; maintenance dose; major...
CZI Crystalline Zinc Insulin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
APECED Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy
BMD Becker Muscular Dystrophy
CHED Congenital Hereditary Endothelial Dystrophy
CMD Congenital muscular dystrophy
CMD Congenital myotonic dystrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • crystalline
    °áÁ¤¼ºÀÇ, °áÁ¤ÁúÀÇ
    ¼ºÁú ¶Ç´Â Åõ¸íµµ¿¡ ÀÖ¾î °áÁ¤°ú ºñ½ÁÇÑ.
  • quasi-crystalline
    ÁذáÁ¤¼ºÀÇ
  • adiposogenital dystrophy
    Áö¹æ »ý½Ä±â ÀÌ¿µ¾çÁõ
    ºóÀÇ ½Å°æÇÐÀÚ Alfred Frohlich¿¡ ÀÇÇØ ÃÖÃÊ·Î ±âÀçµÈ °ÍÀ¸·Î ÇÁ·Ü¸®Èå ºñ¸¸Áõ ¶Ç´Â ½Ã»ó ÇϺμº ºñ¸¸ÁõÀ¸·Îµµ ºÒ¸°´Ù. ½Ã»ó ÇϺΠÁÖº¯ÀÇ Á¾¾ç Áõ»ó, °©Àڱ⠾ÇÈ­ÇÏ´Â ºñ¸¸, ¼º±â ¹ßÀ° ºÎÀüÀÌ 3ÁÖ Áõ»óÀ̰í Ç㸮, ÇϺ¹ºÎ, µÐºÎ µî¿¡ Áö¹æÀÌ Ä§ÂøÇÑ´Ù. »çÃá±â¿¡´Â 2Â÷ ¼ºÂ¡ÀÌ ¿ÀÁö ¾Ê°í ³²¼ºÀÇ °æ¿ì, ¿©¼º°ú °°Àº üÇüÀÌ µÈ´Ù. °ú·Î ½Ã¿¡´Â ½É½ÅÀÇ ÇǷΰ¡ µÎµå·¯Áø´Ù. JonsonÀº ƯÈ÷ ½Ã»ó ÇϺÎÀÇ Á¾¾ç, ±× ¹ÛÀÇ ¿øÀÎÀ¸·Î ÀÎÇÑ ±âÁú Àå¾Ö°¡ ÀÖ´Â »çÃá±â¹ßÁõÀÇ °ÍÀ» ÇÁ·Ü¸®Èå ÁõÈıºÀ̶ó Çϰí À̰ÍÀÌ ¾Æ´Ò ¶§¸¦ Áö¹æ¼º±â¼º ÀÌ¿µ¾çÁõÀ̶ó°í ¸»Çϰí ÀÖ´Ù.
  • adrenogenital dystrophy
    ºÎ½Å ¼º±â ¹ßÀ° ÀÌ»ó, ºÎ½Å ¼º±â ÀÌ¿µ¾çÁõ
  • central areolar choroidal dystrophy
    Á߽ɼº ¿øÇü ¸Æ¶ô¸· ÀÌ¿µ¾ç
  • central cloudy corneal dystrophy
    Á߽ɼº ȥŹ °¢¸· ÀÌ¿µ¾ç
  • distal muscular dystrophy
    ¿øÀ§ ±ÙÀÌ¿µ¾çÁõ
  • dominant cystoid macular dystrophy
    ¿ì¼º ³¶Æ÷ Ȳ¹Ý ÀÌ¿µ¾çÁõ
  • Duchenne pseudohypertrophic muscular dystrophy
    Duchenne À§ºñ´ë¼º ±ÙÀÌ¿µ¾çÁõ
  • dystrophy
    ¹ßÀ° ÀÌ»ó, ÀÌ¿µ¾çÁõ, ¿µ¾ç Àå¾Ö, ÀÌ¿µ¾ç, ¿µ¾ç½ÇÁ¶, ±â´ÉÀå¾Ö, À§ÃàÁõ
    ºÒ¿ÏÀüÇÑ ¿µ¾ç »óÅ·κÎÅÍ À¯¹ßµÇ´Â ±ÙÀ°ÀÇ ¹ßÀ°¼º º¯È­·Î¼­ ÁßÃ߽Űæ°è´Â Æ÷ÇÔÇÏÁö ¾ÊÀ¸¸ç, Áö¹æ º¯¼º, Å©±â´Â Áõ°¡ÇÏÁö¸¸ ÈûÀº °¨¼ÒÇÏ´Â »óŰ¡ Ư¡ÀÌ´Ù. ¿µ¾ç ºÎÁ· ¶Ç´Â ¿µ¾ç °áÇÌ¿¡ À¯·¡ÇÏ´Â ÀÏ¹Ý ÁúȯÀÇ. ƯÈ÷ ±Ù ÀÌ¿µ¾çÀ» ¶æÇÑ´Ù.
  • facioscapulohumeral muscular dystrophy
    ¾È¸é °ß°© »ó¿Ï±Ù ÀÌ¿µ¾çÁõ
  • fascioscapulohumeral dystrophy
    ¾È¸é °ß°© »ó¿Ï ±ÙÀÌ¿µ¾çÁõ
    »ó¿°»öü ¿ì¼ºÀ¸·Î À¯ÀüµÇ°í ±Ù ¼è¾àÀÌ ¾È¸é°ú °ß°©ºÎ ±ÙÀ°¿¡ ÁÖ·Î ³ªÅ¸³ª³ª Èı⿡´Â ´Ù¸® ±ÙÀ°¿¡µµ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. °ß°©ºÎ ±ÙÀ°ÀÌ ÁַΠħ¹üµÇ±â ¶§¹®¿¡ »ó¿Ï À̵αÙÀ̳ª »ï°¢±Ù¿¡¼­ ±Ù »ý°ËÀ» ÇØ¾ßÇÑ´Ù. º´¸®ÇÐÀû ¼Ò°ßÀº ¹Ì¹ÌÇÏ¿© ¸¹Àº ¼öÀÇ È¯ÀÚ¿¡¼­ ±Ù »ý°Ë»ó ¼Ò¼öÀÇ ¿øÇü ±Ù¼¶À¯¸¸ ³ªÅ¸³ª¼­ °ÅÀÇ Á¤»ó ±ÙÀ°°ú °°ÀÌ º¸ÀÏ ¼ö ÀÖ´Ù. ÀϺΠ±Ù¼¶À¯°¡ Á»¸ÔÀº ±Ù¼¶À¯³ª À±»ýºÐÁö ¼¶À¯¸¦ º¸À̰í NADH °°Àº »êÈ­ È¿¼Ò ¿°»ö¿¡ ÁøÇÏ°Ô ¿°»öµÇ´Â ÀûÀº °¢Áø ±Ù¼¶À¯°¡ ³ªÅ¸³ªÁö¸¸ °¢Áø ±Ù¼¶À¯´Â ±ä°æ¿ø¼º ±Ù À§Ãà°ú °°ÀÌ ÁýÇÕÀ» ÀÌ·ç¾î ³ªÅ¸³ªÁö ¾Ê°í Á¤»ó ±Ù¼¶À¯ »çÀÌ¿¡ »êÀçÇÑ´Ù. ºñ´ë ±Ù¼¶À¯µéÀº ÈçÈ÷ ³ªÅ¸³ªÁö¸¸ Á᫐ ÇÙ, ±Ù¼¶À¯ ºÐÇÒ°ú ¼¶À¯È­´Â ÈçÇÏÁö ¾Ê´Ù.
  • juvenile epithelial corneal dystrophy
    ¿¬¼Ò±â °¢¸· »óÇÇ ¼¼Æ÷ ÀÌ¿µ¾çÁõ
  • myotonic dystrophy
    ±Ù ±äÀ强 ÀÌ¿µ¾çÁõ
    ±Ù ±äÀåÁõ°ú ±Ù µð½ºÆ®·ÎÇÇ¿ÍÀÇ ¼º°ÝÀ» Áß½ÉÀ¸·Î ÇÑ ´Ù°èÅ뼺 À¯Àü¼º ÁúȯÀÌ°í ±Ù ±äÀ强 ÁõÈıº¿¡ ¼ÓÇÏ´Â Áúȯ °¡¿îµ¥ °¡Àå ºóµµ°¡ ³ô´Ù. ±Ù ±äÀåÁõÀº ÀÏÁ¾ÀÇ ´ë»ç¼º ¹Ì¿ÀÆÄƼ·Î¼­ÀÇ º´ÅÂÀÌ°í ¼ÕÀ» Áå µÚ Æì±â ¾î·Æ°í ÇØ¸Ó µîÀ¸·Î µÎµé±ä µÚ ±Ù ¼öÃàÀÌ ºÎÇ®¾î¿À¸¥ ÇüÅ·ΠÁö¼ÓÇÏ´Â °Í µîÀÌ Æ¯Â¡ÀÌ´Ù. º¸Åë »ó¿°»öü¼º ¿ì¼º À¯ÀüÀ̰í ÇÑ ´ë°¡ ³»·Á°¥ ¶§¸¶´Ù ¹ß»ý ¿¬·É ÀúÇϳª ÁßÁõÈ­¸¦ ¼ö¹ÝÇÏ´Â ÁøÇ༺ À¯ÀüÀ» ³ªÅ¸³»´Â °æ¿ì°¡ ¸¹´Ù. Ä¡·á´Â ±Ù ±äÀå¿¡ ´ëÇØ¼­´Â ÇÑ·©À» ÇÇÇÏ°í ¿îµ¿ ½Ã¿¡ ¿ö¹Ö¾÷À» ÇÏ´Â ½À°üÀ» ÀÍÈ÷°Ô ÇÏ´Â °ÍÀε¥ ¾à¹° ¿ä¹ýÀ¸·Î¼­ ÇÁ·ÎÄ«ÀξƸ¶À̵å, µðÆä´ÒÈ÷´ÜÅäÀÎ µîÀÇ Ç×°æ·ÃÁ¦µµ ½ÃµµµÈ´Ù. ±Ù·Â ÀúÇÏ¿Í ±Ù À§Ãà¿¡ ´ëÇØ¼­´Â ÀçȰ ÇÁ·Î±×·¥ÀÇ ½Ç½Ã, ´ç´¢º´, ¹é³»Àå µî¿¡ ´ëÇØ¼­´Â °³°³ÀÇ ÀϹÝÀû Ä¡·á¸¦ ÇàÇÑ´Ù.
  • progressive muscular dystrophy
    ÁøÇ༺ ±Ù ÀÌ¿µ¾çÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
buffered crystalline penicillin G Crystalline potassium penicillin G or crystalline sodium penicillin G buffered with not less than 4% and not more than 5% of sodium citrate.
(05 Mar 2000)
poorly crystalline hydroxyapatite amorphous hydroxyapatite
crystalline 1. Clear; transparent.
2. Relating to a crystal or crystals.
(05 Mar 2000)
crystalline capsule The capsule enclosing the lens of the eye.
Synonym: capsula lentis, crystalline capsule, lenticular capsule, phacocyst.
(05 Mar 2000)
crystalline cataract A hereditary cataract with a coralliform or needle-shaped accumulation of crystals in the axial region of an otherwise clear lens.
(05 Mar 2000)
crystalline digitalin <chemical> A cardiac glycoside sometimes used in place of digoxin. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting.
Pharmacological action: anti-arrhythmia agents, cardiotonic agent, enzyme inhibitors.
Chemical name: Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14-hydroxy-, (3beta,5beta)-
(12 Dec 1998)
crystalline insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
crystalline interface In dentistry, a boundary between adjacent crystals.
(05 Mar 2000)
crystalline lens <physics> A transparent optical element, so constructed that it serves to change the degree of convergence or divergence of the transmitted rays.
(05 Aug 1998)
crystalline protein <protein> The major protein found in the lens of the vertebrate eye, it can be dissolved in water easily.
(09 Oct 1997)
lens capsule, crystalline The noncellular outer covering of the crystalline lens, secreted by the embryonic anterior and posterior epithelium. The embryonic posterior epithelium later disappears.
(12 Dec 1998)
lens cortex, crystalline The portion of the crystalline lens surrounding the nucleus and bound anteriorly by the epithelium and posteriorly by the capsule. It contains lens fibres and amorphous, intercellular substance.
(12 Dec 1998)
lens, crystalline The transparent biconvex body of the eye situated between the posterior chamber and the vitreous body, constituting part of the refracting mechanism of the eye.
(12 Dec 1998)
lens nucleus, crystalline The core of the crystalline lens, surrounded by the cortex.
(12 Dec 1998)
adiposogenital dystrophy A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms.
Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism.
Origin: L. Fr. G. Dys-, bad, + trophe, nourishment
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crystalline
    ¼öÁ¤ °°Àº
  • crystalline
    ¼öÁ¤°°Àº;Åõ¸íÇÑ;°áÁ¤(Áú)ÀÇ;°áÁ¤Ã¼·Î µÈ;°áÁ¤Ã¼;(´«¾ËÀÇ)¼öÁ¤Ã¼
  • dystrophy
    ¿µ¾ç ½ÇÁ¶
  • Duvhemme dystrophy
    (ÀÇ)µÚ¼¾Çü ±ÙÀ§ÃàÁõ(±Ù µð½ºÆ®·ÎÇÇÀÇ ÀÏÁ¾)
  • dystrophy
    ¿µ¾ç½ÇÁ¶
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á